European regulators approve diabetes drug by Lilly, Boehringer
Earlier on Thursday, Drugmakers Boehringer Ingelheim and Eli Lilly and Co. announced that their type 2 diabetes treatment Trajenta has
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine